Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation

[1]  T. Braun,et al.  Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality. , 2013, Blood.

[2]  Jack Cuzick,et al.  Lancet Oncol 10 , 2013 .

[3]  R. Porcher,et al.  Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. , 2012, Blood.

[4]  Thomas M Braun,et al.  Plasma biomarkers of lower gastrointestinal and liver acute GVHD. , 2012, Blood.

[5]  R. Porcher,et al.  Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Thomas M Braun,et al.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. , 2011, Blood.

[7]  R. Storb,et al.  Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  T. Schechter,et al.  High alpha‐1 antitrypsin clearance predicts severity of gut graft‐versus‐host disease (GVHD) in children , 2011, Pediatric transplantation.

[9]  I. Papassotiriou,et al.  Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Einstein.

[11]  Michael Boeckh,et al.  Reduced mortality after allogeneic hematopoietic-cell transplantation. , 2010, The New England journal of medicine.

[12]  P. Bartolomeo,et al.  Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants , 2010, Bone Marrow Transplantation.

[13]  H. Einsele,et al.  Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. , 2009, The Lancet. Oncology.

[14]  Thomas M Braun,et al.  A biomarker panel for acute graft-versus-host disease. , 2009, Blood.

[15]  Thomas Braun,et al.  Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. , 2008, Blood.

[16]  S. Yamasaki,et al.  Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  W. Hiddemann,et al.  High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission , 2008, Bone Marrow Transplantation.

[18]  A. Ganser,et al.  Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[19]  Virginia Espina,et al.  Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. , 2006, Experimental hematology.

[20]  J. Treleaven,et al.  Cytokine profiles in stem cell transplantation: Possible use as a predictor of graft-versus-host disease , 2005, Hematology.

[21]  M. Remberger.  Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2005, Haematologica.

[22]  G. Kaysen,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.

[23]  M. Sormani,et al.  A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, γ glutamyl transferase, donor type and cell dose , 2003, Bone Marrow Transplantation.

[24]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[25]  W R Mayr,et al.  Nomenclature for factors of the HLA system, 2002. , 2002, Tissue antigens.

[26]  J. Wagner,et al.  Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  M. Zahurak,et al.  Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  W. Helmberg,et al.  Virtual DNA analysis--a new tool for combination and standardised evaluation of SSO, SSP and sequencing-based typing results. , 1998, Tissue antigens.

[29]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[30]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[31]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.

[32]  S. Weisdorf,et al.  Graft-Versus-Host Disease of the Intestine: A Protein Losing Enteropathy Characterized by Fecal α1-Antitrypsin , 1983 .

[33]  S. Weisdorf,et al.  Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. , 1983, Gastroenterology.

[34]  Steven G.E. Marsh,et al.  Nomenclature for factors of the HLA system , 1975 .